Skip to main content

Mutant Heat-Labile Entertoxins As Adjuvants for CTL Induction

  • Protocol
Vaccine Adjuvants

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 42))

Abstract

Heat-labile enterotoxin (LT) from Escherichia coli and Cholera toxin (CT) from Vibro cholerae are known to be potent mucosal immunogens. These toxins have 80% sequence homology and a similar tertiary structure (1,4), and both elicit potent serum IgG and mucosal IgA responses (5,6). Moreover, both also serve as excellent adjuvants for coadministered antigens. However, they are toxic in their native state and both produce accumulation of intestinal fluid and watery diarrhea (7). LT is the cause of traveler’s diarrhea, whereas CT causes cholera. In order to make use of the adjuvanticity of these molecules but reduce their toxicity, several mutants have been generated by site-directed mutagenesis. Of these, there are two mutants of the enzymatic A subunit, LTK63 and LTR72, that maintain a high level of immunogenicity and have significant potential as adjuvants. This chapter will focus on the use of LTK63 and LTR72 as intramuscular and intranasal adjuvants for the induction of cytotoxic T lymphocytes (CTL) activity against coadministered protein immunogens.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Magagnoli, C., Manetti, R., Fontana, M. R., Giannelli, V., Giuliani, M. M., Rappuoli, R., et al. (1996) Mutations in the A subunit affect yield, stability, and protease sensitivity of nontoxic derivatives of heat labile enterotoxin. Infection and Immunity 64, 5434–5438.

    PubMed  CAS  Google Scholar 

  2. Dallas, W. S. and Falkow, S. (1980) Amino acid homology between cholera toxin and Escherichia coli heat labile toxin. Nature 288, 499–501.

    CAS  Google Scholar 

  3. Spicer, E. K., Kavanaugh, W. M., Dallas, W. S., Falkow, S., Konisberg, W. H., and Shafer, D. (1981) Sequence homologies between A subunits of E. Coli and V. cholerae enterotoxin. Proc. Natl. Acad. Sci. USA 78, 50–54.

    Article  PubMed  CAS  Google Scholar 

  4. Yamamoto, T., Tamura, T., and Yokota, T. (1984) Primary structure of heat-labile enterotoxin produced by Escherichia coli pathogenic for humans. J. Biol. Chem. 259, 5037–5044.

    PubMed  CAS  Google Scholar 

  5. Clements, J. D. and Dickinson, B. L. (1996) Use of Escherichia coli heat-labile enterotoxin as an oral adjuvant, in Mucosal Vaccines (Kiyono, H., Ogra, P. L., and McGhee, J. R., eds.), Academic, London and New York, pp. 73–87.

    Google Scholar 

  6. Douce, G., Turcotte, C., Cropley, I., Roberts, M., Pizza, M., Domenighini, M., et al. (1995) Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc. Natl. Acad. Sci. USA 92, 1644–1648.

    Article  PubMed  CAS  Google Scholar 

  7. Pizza, M., Fontana, M. R., Giuliani, M. M., Domenighini, M., Magagnoli, C., Giannelli, V., et al. (1994) A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A sub-unit. J. Exp. Med. 180, 2147–2153.

    Article  PubMed  CAS  Google Scholar 

  8. Holmgren, J., Lonnroth, I., and Svennerholm, L. (1973) Tissue receptor for cholera exotoxin: postulated structure from studies with GM1-ganglioside and related glycolipids. Infect. Immun. 8, 208–214.

    PubMed  CAS  Google Scholar 

  9. Sugii, S. T. (1989) Binding specificities of heat-labile enterotoxins isolated from porcine and human enterotoxigenic Escherichia coli heat-labile toxin and cholera toxin. Can. J. Microbiol. 35, 670–673.

    Article  PubMed  CAS  Google Scholar 

  10. Pizza, M., Fontana, M. R., Scarlato, V., and Rappuoli, R. (1996) Genetic detoxification of bacterial toxins in, Methods in Molecular Medicine: Vaccine Protocols (Robinson, A., Farrar, G., and Wiblin, C., eds.), Humana, Totowa, NJ, pp. 91–109.

    Chapter  Google Scholar 

  11. Lycke, N. and Holmgren, J. (1992) The adjuvant effect of Vibro cholerae and Escherichia coli heat-labile enterotoxins is linked to ADP-ribosyltransferase activity. Eur. J. Immunol. 22, 2277.

    Article  PubMed  CAS  Google Scholar 

  12. Di Tommaso, A., Saletti, G., Pizza, M., Rappuoli, R., Dougan, G., Abrignani, S., et al. (1996) Induction of antigen specific antibodies in vaginal secretions by using a nontoxic mutant heat-labile enterotoxin as a mucosal adjuvant. Infect. Immun. 64, 974–979.

    PubMed  Google Scholar 

  13. Partidos, C. D., Pizza, M., Rappuoli, R., and Steward, M. W. (1996) The adjuvant effect of a non-toxic mutant heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide. Immunology 89, 483–487.

    Article  PubMed  CAS  Google Scholar 

  14. Clements, J. D. and Finkelstein, R. A. (1979) Isolation and characterization of homogeneous heat-labile enterotoxin with high specific activity from Escherichia coli cultures. Infect. Immun. 24, 760–769.

    PubMed  CAS  Google Scholar 

  15. Clements, J. D., Yancy, R. J., and Finkelstein, R. A. (1980) Properties of homogeneous heat-labile enterotoxin from Escherichia coli. Infect. Immun. 29, 91–97.

    CAS  Google Scholar 

  16. Pizza M., Domenighini M., Hoi, W., Giannelli, V., Fontana, M. R., Giuliani, M. M., et al. (1994) Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis. Mol. Microb. 14, 51–60.

    Article  CAS  Google Scholar 

  17. Pizza, M., Fontana, M. R., Giuliani, M. M., Domenighini, M., Magagnoli, C., Giannelli, V., et al. (1994) A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A sub-unit. J. Exp. Med. 180, 2147–2153.

    Article  PubMed  CAS  Google Scholar 

  18. Giuliani, M. M., Del Giudice, G., Giannelli, V., Dougan, G., Douce, D., Rappuoli, R., et al. (1998) Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity. J. Exp. Med. 187, 1–10.

    Article  Google Scholar 

  19. Doe, B. and Walker, C. M. (1996) HIV-1 p24 gag-specific cytotoxic T-lymphocyte responses in mice. Correspondence, AIDS 10, 793–806.

    Article  CAS  Google Scholar 

  20. Elvin, J., Cerundolo, V., Elliott, T., and Townsend, A. (1991) A quantitative assay of peptide-dependant class I assembly. Eur. J. Immunol. 21, 2025–2031.

    Article  PubMed  CAS  Google Scholar 

  21. Paliard, X., Doe, B., and Walker, C. M. (1998) The T cell repertoire primed by antiviral vaccination is influenced by self-tolerance. Cellular Immunol. 188, 73–79.

    Article  CAS  Google Scholar 

  22. Doe, B., Steimer, K. S., and Walker, C. M. (1994) Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO-derived gp120 is enhanced by enzymatic removal of N-linked glycans. Euro. J. Immunol. 24, 2369–2376.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Humana Press Inc.

About this protocol

Cite this protocol

Neidleman, J.A., Ott, G., O’Hagan, D. (2000). Mutant Heat-Labile Entertoxins As Adjuvants for CTL Induction. In: O’Hagan, D.T. (eds) Vaccine Adjuvants. Methods in Molecular Medicine™, vol 42. Springer, Totowa, NJ. https://doi.org/10.1385/1-59259-083-7:327

Download citation

  • DOI: https://doi.org/10.1385/1-59259-083-7:327

  • Publisher Name: Springer, Totowa, NJ

  • Print ISBN: 978-0-89603-735-9

  • Online ISBN: 978-1-59259-083-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics